Fact CheckerSign in

NCT07435025Active, not recruiting

Surgery for Obstructed Gastric Carcinoma

Palliative Resection Versus Palliative Bypass in Obstructed Locally Advanced Gastric Carcinoma

Source: ClinicalTrials.gov · Last updated 27 Feb 2026

Brief summary (registry, in English)

The goal of this clinical trial is to find the best treatment for obstructed gastric carcinoma in gastric cancer patients. It will include all patients with obstructed gastric cancer with different ages and sex who consented to share in the trial. The main question is what is the better for management for obstructed gastric cancer; palliative resection or palliative bypass? We hypothesized that resection is better. patients will be divided into two groups. the primary outcome measure will be the relief of obstruction

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
63 (estimated)
First submitted
19 Feb 2026
Start date
1 Feb 2026
Primary completion date
1 Feb 2027
Lead sponsor
Zagazig University
NCT number
NCT07435025

What you commit to

  • Study type: Interventional
  • Planned participants: 63
  • From 1 Feb 2026 to the primary completion date, 1 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • non obstructed gastric cancer patients

Who the study is looking for

  • emergency obstructed gastric cancer patients

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Medicine Zagazig University
Coordinator of this site? Confirm its status
ZagazigEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.